Juvenile Arthritis Treatment
幼年关节炎治疗
Duration
6-12 months initial treatment
Recovery
8-12 weeks for initial response; ongoing management through growth
Savings
~75% vs US
Average savings compared to US prices
Specialized pediatric rheumatology care for juvenile idiopathic arthritis (JIA) using biologic agents, methotrexate, and rehabilitation programs designed for growing children. China's pediatric rheumatology centers provide family-centered care with expertise in all JIA subtypes. Treatment goals include disease remission, normal growth, and prevention of joint damage.
Pediatric Rheumatology Assessment
Joint examination, growth evaluation, eye screening for uveitis, laboratory workup, and JIA subtype classification
Duration: 1-2 daysFirst-line Treatment
NSAIDs and intra-articular corticosteroid injections for oligoarticular disease; methotrexate for polyarticular involvement
Duration: 1-3 monthsBiologic Escalation
TNF inhibitors (etanercept, adalimumab) or IL-6 blockers (tocilizumab) for inadequate DMARD response
Duration: 3-6 monthsGrowth & Rehabilitation Monitoring
Regular growth assessments, ophthalmology screening, physical therapy, and psychosocial support
Duration: Ongoing- Affordable biologic therapy for pediatric patients
- Family-centered care with parent education programs
- Growth monitoring integrated into treatment planning
- Access to pediatric rheumatology specialists
- Growth impacts from chronic inflammation or steroid use
- Uveitis risk requiring regular eye screening
- Long-term immunosuppression in developing immune systems
- Psychological impacts on child development
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.